F19.182
Other psychoactive substance abuse with psychoactive substance-induced sleep disorder
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F19.182 describes a condition where an individual abuses multiple psychoactive substances, which leads to a sleep disorder caused by the effects of these substances. This condition reflects the complex relationship between substance use and sleep quality, highlighting the importance of addressing both substance abuse and sleep issues for overall well-being.
Causes & Symptoms
Clinical Causes: Repeated or excessive use of various psychoactive substances such as stimulants, depressants, or hallucinogens. Use of substances that alter brain chemistry and regulation of sleep-wake cycles. Misuse or dependency on substances to manage stress, anxiety, or other emotional issues.
Key Symptoms: Difficulty falling asleep or staying asleep Vivid or disturbing dreams Nightmares or restless sleep Daytime fatigue or drowsiness Episodic wakefulness during the night Feeling unrefreshed after sleep
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a thorough medical history examining substance use patterns and sleep habits. Healthcare providers may utilize questionnaires, sleep studies, and blood tests to identify the specific substances involved and assess their impact on sleep. Recognizing overlapping symptoms of substance abuse and sleep disturbance is crucial for accurate diagnosis.
Treatment Protocols: Treatment strategies often include a combination of approaches such as:
Clinical Advice & FAQs
Billing Guidance
Is F19.182 a billable ICD-10 code?
Yes, F19.182 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.182?
Clinical documentation must specify the nature of Other psychoactive substance abuse with psychoactive substance-induced sleep disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference